# A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

> **NCT06335888** · PHASE2 · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 70 (estimated)

## Conditions studied

- Giant Cell Arteritis

## Interventions

- **DRUG:** AzaFol
- **DRUG:** FDG

## Key facts

- **NCT ID:** NCT06335888
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2029-05
- **Final completion:** 2029-05
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06335888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06335888, "A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06335888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*